Efficacy and Safety of Quetiapine compared with Valproate in the Treatment of Patients with Bipolar Disorder and Rapid Cycling

Study identifier:5077/9061

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Pilot Study of the Efficacy and Safety of Quetiapine compared with Valproate in the Treatment of Patients with Bipolar Disorder and Rapid Cycling: an open trial

Medical condition

Bipolar Disorder

Phase

Phase 3

Healthy volunteers

Study drug

quetiapine fumarate or valproate

Sex

All

Actual Enrollment

Study type

Interventional

Age

18 Years - 65 Years

Date

Study Start Date: 01 Jan 2002

Primary Completion Date: -

Study Completion Date: 01 Mar 2006

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2007 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca GmbH Information

+49 62 02 99 00

Investigators

Principal Investigator

AstraZeneca Germany Medical Director

AstraZeneca GmbH